RxRevu is a provider of Prescription Decision Support (PDS) to deliver real-time, patient-specific cost information, electronic prior authorization, and therapeutic alternatives at the point of care. Its technology platform, SwiftRx, offers solutions to promote cost transparency, support data-driven medication savings opportunities, and enable shared decisions between providers and patients.
|Employees (est.) (Nov 2019)||37||(+6%)|
RxRevu total Funding
RxRevu latest funding size
Time since last funding
|6 months ago|
|Jazz Venture Partners, Froedtert Health, UCHealth, UnityPoint Health, UVA Licensing & Ventures Group, Presbyterian Healthcare Services, Children’s Hospital Colorado|
RxRevu has 1.03k Twitter Followers. The number of followers has increased 0.6% month over month and increased 1.3% quarter over quarter
When was RxRevu founded?
RxRevu was founded in 2013.
How many employees does RxRevu have?
RxRevu has 37 employees.
Who are RxRevu competitors?
Competitors of RxRevu include Velabs Therapeutics, DermBiont and Olio.
Where is RxRevu headquarters?
RxRevu headquarters is located at 2601 Blake St #450, Denver.
Where are RxRevu offices?
RxRevu has an office in Denver.
How many offices does RxRevu have?
RxRevu has 1 office.
Receive alerts for 300+ data fields across thousands of companies